#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infertility male Acute leukaemia Inflammatory myofibroblastic tumour Congenital absence of bile ducts Synovial sarcoma Corneal neovascularisation Anaplastic thyroid cancer Glomerulonephritis membranoproliferative Sickle cell disease Congenital leptin deficiency Myxoid liposarcoma Microscopic polyangiitis Small cell lung cancer limited stage Metastatic malignant melanoma Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Brain stem glioma Mantle cell lymphoma stage II – Life with Disease Haemophilia A with anti factor VIII – Treatment Leiomyosarcoma – Diagnostics Alternating hemiplegia of childhood – Diagnostics Familial haemophagocytic lymphohistiocytosis – Trials in Disease Retinitis pigmentosa – Trials in Disease Adrenocortical carcinoma – Trials in Disease Hereditary ataxia – Life with Disease Focal segmental glomerulosclerosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADCE-D01 Ertapenem Sodium Nitrous Oxide Peposertib WEF-001 Munc-T3 SECRETIN SYNTHETIC HUMAN Benralizumab Zanubrutinib Lonvoguran Dexamethasone Acetate Ph. Eur. Metyrapone Jab-21822 Triheptanoin Axatilimab Aficamten Acp-017 Flutamide Eight Treg Mianserin Hydrochloride More therapies…

    Learn about Your Condition

    Naevoid melanoma Cerebral amyloid angiopathy Neuralgia Infant sedation Radiation skin injury Polyneuropathy Myxoid liposarcoma Rasmussen encephalitis Infectious pleural effusion Coronary artery bypass Diabetic retinal oedema Renal cell carcinoma stage IV HER2 positive breast cancer Peripheral spondyloarthritis Spinal cord injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastric cancer

  • Study on Ramucirumab and Paclitaxel for Older Patients with Advanced Stomach Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Ramucirumab
    • Paclitaxel
    France

  • Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Denmark

  • Study on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Octreotide
    Sweden

  • Study of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Adenocarcinoma gastric
    • Gastric cancer
    Investigated Drugs:
    • Sirexatamab
    • Tislelizumab
    • Capecitabine
    Germany

  • Study of Zanidatamab and Tislelizumab Combined with Chemotherapy for Patients with Advanced or Metastatic HER2-positive Gastroesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Loperamide
    • Tislelizumab
    • Capecitabine
    Belgium Estonia France Germany Greece Ireland +6
Previous Page
1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!